{"protocolSection":{"identificationModule":{"nctId":"NCT02253004","orgStudyIdInfo":{"id":"H-3-2013-166"},"secondaryIdInfos":[{"id":"2013-004188-29","type":"EUDRACT_NUMBER"}],"organization":{"fullName":"Herlev Hospital","class":"OTHER"},"briefTitle":"Induction of Migraine Aura With Cilostazol","officialTitle":"The Effect of the Selective PDE3 Inhibitor on Migraine With Aura Induction and Vascular Endothelial Function."},"statusModule":{"statusVerifiedDate":"2015-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2014-09"},"primaryCompletionDateStruct":{"date":"2015-08","type":"ACTUAL"},"completionDateStruct":{"date":"2015-08","type":"ACTUAL"},"studyFirstSubmitDate":"2014-09-26","studyFirstSubmitQcDate":"2014-09-30","studyFirstPostDateStruct":{"date":"2014-10-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-08-20","lastUpdatePostDateStruct":{"date":"2015-08-21","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Christina Kruuse","investigatorTitle":"Associate professor, consultant neurologist","investigatorAffiliation":"Herlev Hospital"},"leadSponsor":{"name":"Herlev Hospital","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"In a double blind placebo-controlled cross-over study the effect of cilostazol on aura induction and endothelial response is tested in patient with migraine with aura.","detailedDescription":"Migraine with aura is associated to an increased risk of stroke. The mechanism behind such increased risk is not fully understood. Cilostazol induce headache and migraine in migraine patients and is used as secondary prevention of stroke. The effect on aura induction is not known. We investigate the aura inducing potential of cilostazol and associated changes in endothelial function."},"conditionsModule":{"conditions":["Migraine With Aura","Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["EARLY_PHASE1"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"CROSSOVER","primaryPurpose":"BASIC_SCIENCE","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":16,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Active","type":"EXPERIMENTAL","description":"Cilostazol 200 mg single dose","interventionNames":["Drug: Cilostazol"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Placebo capsule","interventionNames":["Drug: Placebo"]}],"interventions":[{"type":"DRUG","name":"Cilostazol","description":"Single oral administration of active or placebo one week apart","armGroupLabels":["Active"],"otherNames":["Pletal"]},{"type":"DRUG","name":"Placebo","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Aura","description":"Induction of aura reported by an aura diary for 24 hours post medication","timeFrame":"24 hours"}],"secondaryOutcomes":[{"measure":"Migraine","description":"Induction of headache resembling usual migraine attacks","timeFrame":"24 hours"},{"measure":"Endothelial response","description":"Measurement of endothelial response by Endopat2000 before and after administration of placebo and cilostazol","timeFrame":"3 hours"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Migraine with aura\n* Minimum of 2 attacks/year\n\nExclusion Criteria:\n\n* Chronic tension type headache\n* Cardiac arrhythmias","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"50 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Christina Kruuse, MD PhD DMSc","affiliation":"Consultant Neurologist, Dept Neurology","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Herlev Hospital, Dept Neurology","city":"Herlev","zip":"2730","country":"Denmark","geoPoint":{"lat":55.72366,"lon":12.43998}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000008881","term":"Migraine Disorders"},{"id":"D000020325","term":"Migraine with Aura"}],"ancestors":[{"id":"D000051270","term":"Headache Disorders, Primary"},{"id":"D000020773","term":"Headache Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M11542","name":"Migraine Disorders","asFound":"Migraine","relevance":"HIGH"},{"id":"M21824","name":"Migraine with Aura","asFound":"Migraine With Aura","relevance":"HIGH"},{"id":"M9041","name":"Headache","relevance":"LOW"},{"id":"M22219","name":"Headache Disorders","relevance":"LOW"},{"id":"M26347","name":"Headache Disorders, Primary","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000077407","term":"Cilostazol"}],"ancestors":[{"id":"D000001993","term":"Bronchodilator Agents"},{"id":"D000001337","term":"Autonomic Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000018927","term":"Anti-Asthmatic Agents"},{"id":"D000019141","term":"Respiratory System Agents"},{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000010975","term":"Platelet Aggregation Inhibitors"},{"id":"D000014665","term":"Vasodilator Agents"},{"id":"D000018696","term":"Neuroprotective Agents"},{"id":"D000020011","term":"Protective Agents"},{"id":"D000058987","term":"Phosphodiesterase 3 Inhibitors"},{"id":"D000010726","term":"Phosphodiesterase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"}],"browseLeaves":[{"id":"M1788","name":"Cilostazol","asFound":"Stored","relevance":"HIGH"},{"id":"M29023","name":"Phosphodiesterase 3 Inhibitors","relevance":"LOW"},{"id":"M4959","name":"Bronchodilator Agents","relevance":"LOW"},{"id":"M20653","name":"Anti-Asthmatic Agents","relevance":"LOW"},{"id":"M20827","name":"Respiratory System Agents","relevance":"LOW"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"},{"id":"M20463","name":"Neuroprotective Agents","relevance":"LOW"},{"id":"M21559","name":"Protective Agents","relevance":"LOW"},{"id":"M13319","name":"Phosphodiesterase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"}],"browseBranches":[{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"NeuroAg","name":"Neuroprotective Agents"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"Resp","name":"Respiratory System Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}